Highlights
News Desk, AnyTV, New Delhi
Published by: Abhishek Dixit
Updated Sat, 19 Feb 2022 08:12 PM IST
Summary
The company said that AccuGen has announced that the US Food and Drug Administration (FDA) has approved Covaxin as a corona vaccine candidate. AccuGen is partnering to manufacture Covaxin in the US and Canada.
hear the news
Expansion
The country’s indigenous vaccine ‘Covaxin’ will now be considered as a corona vaccine candidate in the US. Bharat Biotech gave this information on Saturday. The company said that AccuGen has announced that the US Food and Drug Administration (FDA) has approved Covaxin as a corona vaccine candidate. AccuGen is partnering to manufacture Covaxin in the US and Canada. According to the World Health Organization, Covaxin has already been listed on the Emergency Use List (EUL) in 13 countries as of January 31.
The condition of Corona in major states and cities of the country
- In the last 24 hours, 6,757 new cases of corona have been reported in Kerala. During this 16 people died and 17,086 people were discharged. The total active cases stand at 75,017.
- 635 new cases of corona virus were reported in Delhi. During this, two deaths occurred and 791 recoveries took place. Active cases are 2,617.
- The number of corona vaccinations in the country has crossed 175.33 crores. More than 27 lakh doses of the vaccine have been administered till 7 pm on Saturday.
- Union Health Minister Mansukh Mandaviya said that 80 percent of the adult population of the country has been fully immunized against COVID-19.